Eli Lilly & Co. (LLY)

109.70
1.80 1.67
NYSE : Health Technology
Prev Close 107.90
Open 108.35
Day Low/High 108.22 / 110.10
52 Wk Low/High 104.17 / 132.13
Volume 1.76M
Avg Volume 3.54M
Exchange NYSE
Shares Outstanding 965.43M
Market Cap 104.61B
EPS 3.10
P/E Ratio 25.74
Div & Yield 2.58 (2.34%)
Eli Lilly Breaks Out of a Large Consolidation Pattern, Further Gains Ahead

Eli Lilly Breaks Out of a Large Consolidation Pattern, Further Gains Ahead

The weekly breakout is pretty impressive on the charts, so let's take a look.

Jim Cramer: 4 Pet-Related Stocks That Are Top Dog

Jim Cramer: 4 Pet-Related Stocks That Are Top Dog

The humanization of pets theme is driving outstanding earnings and share price growth for these 4 names.

Jim Cramer: How to Pick Stocks When the Market Is Flying Blind

Jim Cramer: How to Pick Stocks When the Market Is Flying Blind

This market clearly has no clue what to buy, with strong GDP growth but challenging trade dynamics and the Facebook and Twitter bombs last week.

The Race to Cure Alzheimer's is On: These Are the Forerunners

The Race to Cure Alzheimer's is On: These Are the Forerunners

Top pharmaceutical companies are paving the way to a cure for Alzheimer's, a degenerative disease that is affecting millions around the world.

Jim Cramer: We've Got an Extremist Market

Jim Cramer: We've Got an Extremist Market

Don't buy up when there's nothing but rampant pin action.

3 Ways to Play Facebook Ahead of Wednesday's Earnings

3 Ways to Play Facebook Ahead of Wednesday's Earnings

Here are some options strategies for this FANG name into tomorrow's report.

Eli Lilly Downgraded to Hold at DZ Bank

Latest Reasons to Avoid Alzheimer's Plays

Latest Reasons to Avoid Alzheimer's Plays

Eli Lilly, AstraZeneca and vTv Therapeutics show why it's best to stay away from biotech's black hole.

Jim Cramer: Many Reasons Why a Stock Market You Think Should Go Down, Doesn't

Jim Cramer: Many Reasons Why a Stock Market You Think Should Go Down, Doesn't

You should be thinking positively these days if your stock has had a run or even if it hasn't as a preponderance of good things is liable to happen.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

All three major averages closed Thursday's session in positive territory.

Feels Like the Semis Are Skating on Thin Ice: Market Recon

Feels Like the Semis Are Skating on Thin Ice: Market Recon

Forward looking valuations, except for Nvidia, are very low.

Here's My Take on Biotech Stocks

Here's My Take on Biotech Stocks

I think M&A activity will pick up markedly going forward across the industry.

Women's History Month: Nancy Lieberman -- Still Law Firm's Youngest Partner Ever

Women's History Month: Nancy Lieberman -- Still Law Firm's Youngest Partner Ever

For Women's History Month, Alpha Rising sat down with Nancy Lieberman, Of Counsel at Skadden, Arps. She was and still is the youngest person to ever make partner at her firm. She has worked on some of the biggest M&A deals in history -- and we should mention -- she's in a wheelchair and barely as use of her hands. Feel like a slacker yet? Good. Watch.

Eli Lilly: Is the Coast Now Clear for the Bulls?

Eli Lilly: Is the Coast Now Clear for the Bulls?

Traders should stay alert and nimble with LLY stock.

Eli Lilly Needs to Prove It Can Overcome Resistance Above $82

Eli Lilly Needs to Prove It Can Overcome Resistance Above $82

The price of LLY has climbed and the bearish price target on the Point and Figure chart is off the table.

Intermediate Trade: Eli Lilly

Intermediate Trade: Eli Lilly

Consider this LLY bullishly biased vertical call spread expiring in June.

Jim Cramer: Drug Stocks on the Move

Jim Cramer: Drug Stocks on the Move

We could be poised for even a further advance PROVIDED that we stay oversold.

Here's How Eli Lilly Stock Can Regain Its Footing

Here's How Eli Lilly Stock Can Regain Its Footing

Watch these key price levels on LLY.

Intermediate Trade: Eli Lilly

Intermediate Trade: Eli Lilly

Consider this LLY out of the money, bullishly biased vertical call spread expiring in April.

Jim Cramer: I Wish Some Stocks Would Not Keep Rallying

Jim Cramer: I Wish Some Stocks Would Not Keep Rallying

Facebook is making itself a tough own ahead of the quarterly results.

Big Pharma and the Sellers of Its Products Now Have a Problem

Big Pharma and the Sellers of Its Products Now Have a Problem

Who, out there in the health care sector, is safe?

A Rally in Eli Lilly Could Heal Traders, Investors

A Rally in Eli Lilly Could Heal Traders, Investors

Prices have improved the past eight weeks and now I want to turn up the volume.

Intermediate Trade: Eli Lilly

Intermediate Trade: Eli Lilly

This is a bullish trade, but it's best to use limit orders.

Some Afternoon Observations

* Thus far, my expectation of an "inside day" has been accurate. SPDR S&P 500 ETF  has traded in a fifty cent range most of the day. * Bonds are at the day's highs. +$0.88. Yield on the 10-year U.S. note is down by 3.5 basis points to 2.32% (where y...

Notable Movements

In terms of sector price movement today: * FANGs continue to extend recent gains.  * Retail has picked up a bid late in the day. Walmart Dillard's and Foot Locker are upside features. * Big Pharma stronger -- led by Merck ,Bristol-Myers Squibb , Lil...

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The Dow had a record high close.